
Adaptive Biotechnologies (NASDAQ:ADPT) brought in sales totaling $38.62 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 2.35%, resulting in a loss of $62.80 million. In Q4, Adaptive Biotechnologies brought in $37.93 million in sales but lost $61.36 million in earnings.